The FDA has issued important safety warnings regarding semaglutide and thyroid concerns, specifically related to thyroid C-cell tumors observed in animal studies
Most patients report reduced appetite within 1-2 weeks of dose escalation
Originally developed to manage type 2 diabetes, these drugs are now widely prescribed for weight loss, often referred to as skinny jabs. Social media conversations, pharmacy waitlists, and rising GP consultations reflect a nationwide shift in how people approach weight management
Gives You a Glow: If you use it regularly, your skin will look better by reducing dryness and enhancing its natural glow
Genetic variants in the GLP1R gene, FTO, MC4R, and GIPR may influence appetite regulation, weight loss trajectory, and side effect susceptibility
We rely on trusted primary sources, including peer-reviewed research, academic institutions, and leading medical organizations